|
Volumn 23, Issue 6, 2016, Pages 959-960
|
Opposing Effects of Antidiabetic Interventions on Malignant Growth and Metastasis
|
Author keywords
[No Author keywords available]
|
Indexed keywords
DIPEPTIDYL PEPTIDASE IV INHIBITOR;
REACTIVE OXYGEN METABOLITE;
TRANSCRIPTION FACTOR NRF2;
ANTIDIABETIC AGENT;
CANCER GROWTH;
CARCINOGENESIS;
DRUG EFFECT;
HUMAN;
INTERVENTION STUDY;
METASTASIS;
METASTASIS POTENTIAL;
PRIORITY JOURNAL;
REVIEW;
ANIMAL;
BIOLOGICAL MODEL;
CELL PROLIFERATION;
DIABETES MELLITUS, TYPE 2;
DRUG EFFECTS;
METABOLISM;
MITOCHONDRION;
NEOPLASMS;
PATHOLOGY;
ANIMALS;
CELL PROLIFERATION;
DIABETES MELLITUS, TYPE 2;
HUMANS;
HYPOGLYCEMIC AGENTS;
MITOCHONDRIA;
MODELS, BIOLOGICAL;
NEOPLASM METASTASIS;
NEOPLASMS;
REACTIVE OXYGEN SPECIES;
|
EID: 84975466423
PISSN: 15504131
EISSN: 19327420
Source Type: Journal
DOI: 10.1016/j.cmet.2016.05.017 Document Type: Short Survey |
Times cited : (8)
|
References (10)
|